Tham khảo Deferiprone

  1. 1 2 Savulescu, J (2004). “Thalassaemia major: The murky story of deferiprone”. BMJ 328 (7436): 358–9. PMC 341373. PMID 14962851. doi:10.1136/bmj.328.7436.358. 
  2. ↑ Staff, Cipla. Cipla's History
  3. ↑ FDA NEWS RELEASE: FDA Approves Ferripox (deferiprone) to Treat Patients with Excess Iron in the Body, Oct. 14, 2011 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm275814.htm
  4. ↑ Viens, A M; Savulescu, J (2004). “Introduction to the Olivieri symposium”. Journal of Medical Ethics 30 (1): 1–7. PMC 1757126. PMID 14872065. doi:10.1136/jme.2003.006577. 
  5. ↑ Brittenham, G. M; Nathan, D. G; Olivieri, N. F; Porter, J. B; Pippard, M; Vichinsky, E. P; Weatherall, D. J (2003). “Deferiprone and hepatic fibrosis”. Blood 101 (12): 5089–90; author reply 5090–1. PMID 12788794. doi:10.1182/blood-2002-10-3173. 
  6. ↑ Wanless, I. R; Sweeney, G; Dhillon, A. P; Guido, M; Piga, A; Galanello, R; Gamberini, M. R; Schwartz, E; Cohen, A. R (2002). “Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia”. Blood 100 (5): 1566–9. PMID 12176871. doi:10.1182/blood-2002-01-0306. 
  7. ↑ Cribb, Robert (27 tháng 2 năm 2019). “UHN patients given unlicensed drug that led to diabetes, liver dysfunction and one death, study finds”. The Star (bằng tiếng Anh). Toronto. Truy cập ngày 27 tháng 2 năm 2019. 

Liên quan

Tài liệu tham khảo

WikiPedia: Deferiprone http://www.chemspider.com/Chemical-Structure.2866.... http://www.cipla.com/Home/About-Us/History.aspx http://www.drugs.com/international/deferiprone.htm... http://www.ema.europa.eu/ema/index.jsp?curl=/pages... http://www.fda.gov/NewsEvents/Newsroom/PressAnnoun... //www.ncbi.nlm.nih.gov/pmc/articles/PMC1757126 //www.ncbi.nlm.nih.gov/pmc/articles/PMC341373 //www.ncbi.nlm.nih.gov/pubmed/12176871 //www.ncbi.nlm.nih.gov/pubmed/12788794 //www.ncbi.nlm.nih.gov/pubmed/14872065